Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.47 |
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA9 | Q16790 | 6/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.47 |
| ▸ | CA5A | P35218 | 4/20 | 0.47 |
| ▸ | CA3 | P07451 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 3/20 | 0.47 |
| ▸ | CA6 | P23280 | 3/20 | 0.47 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.45 |
| ▸ | ALPI | P09923 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL929164 | 0.78 | ALPL (0.53) | CA1CA2CA9CA12CA14 | |
| SCHEMBL18263202 | 0.77 | CA2 (0.49) | CA1CA2CA9CA12CA14 | |
| SCHEMBL8623279 | 0.77 | TDP1 (0.50) | CA1CA2CA9CA12CA14 | |
| SCHEMBL952515 | 0.77 | KEAP1 (0.45) | CA1CA2CA9CA12CA5A | |
| SCHEMBL4538720 | 0.77 | PLCG1 (0.45) | CA1CA2CA9CA12CA14 | |
| SCHEMBL927603 | 0.77 | ALDH1A1 (0.57) | CA1CA2CA9CA12CA14 | |
| SCHEMBL4119819 | 0.76 | TDP1 (0.48) | CA1CA2CA9CA12CA7 | |
| SCHEMBL29657456 | 0.76 | CA2 (0.55) | CA1CA2CA9CA12CA14 | |
| SCHEMBL29488753 | 0.75 | CA2 (0.59) | CA1CA2CA9CA12CA14 | |
| SCHEMBL997443 | 0.75 | CA2 (0.59) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114784378-A | Electrolyte added with 4-nitrobenzenesulfonic acid pentafluorophenyl ester and homolog and lithium battery | 湖南大学 | 2022-07-22 | — | — | CN | claimed |
| US-8816062-B2 | Maleimide-furanyl compounds that can be used in a general method for preparing maleimide-oligonucleotide derivatives | UNIVERSITAT DE BARCELONA (ES) | 2014-08-26 | — | — | US | claimed |
| US-20130158248-A1 | MALEIMIDE-FURANYL COMPOUNDS THAT CAN BE USED IN A GENERAL METHOD FOR PREPARING MALEIMIDE-OLIGONUCLEOTIDE DERIVATIVES | UNIVERSITAT DE BARCELONA (ES) | 2013-06-20 | — | — | US | claimed |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | INSTITUT CURIE (FR) | 2026-05-21 | — | — | US | disclosed |
| US-12527854-B2 | Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof | INSTITUT CURIE (FR) | 2026-01-20 | — | — | US | disclosed |
| US-20250385912-A1 | METHODS AND COMPOSITIONS FOR SYNTHESIS OF THERAPEUTIC NANOPARTICLES | DANTARI INC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250152734-A1 | USES AND FORMULATIONS OF CAMPTOTHECIN (CPT)-CONTAINING NANOPARTICLES | DANTARI INC (US) | 2025-05-15 | — | — | US | disclosed |
| US-20250002531-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS INC. (US) | 2025-01-02 | — | — | US | disclosed |
| CN-119013047-A | Use and formulation of Camptothecin (CPT) containing nanoparticles | 丹塔里股份有限公司 | 2024-11-22 | — | — | CN | disclosed |
| US-12037414-B2 | Processes for preparing pharmaceutically relevant peptides | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2024123732-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF PROSTATE CANCER | Dantari, Inc. (US) | 2024-06-13 | — | — | WO | disclosed |
| EP-3265109-B1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2020-10-21 | — | — | EP | disclosed |
| US-20200308221-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2020-10-01 | — | — | US | disclosed |
| US-10633415-B2 | Processes for preparing pharmaceutically relevant peptides | STEALTH BIOTHERAPEUTICS CORP (MC) | 2020-04-28 | — | — | US | disclosed |
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS INC. | 2018-02-15 | — | — | US | disclosed |
| EP-3265109-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | Stealth BioTherapeutics Corp (MC) | 2018-01-10 | — | — | EP | disclosed |
| CN-107530395-A | Method for producing drug-related peptides | 康德生物医疗技术公司 | 2018-01-02 | — | — | CN | disclosed |
| WO-2016144905-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2016-09-15 | — | — | WO | disclosed |
| US-8816062-B2 | Maleimide-furanyl compounds that can be used in a general method for preparing maleimide-oligonucleotide derivatives | UNIVERSITAT DE BARCELONA (ES) | 2014-08-26 | — | — | US | disclosed |
| US-20130158248-A1 | MALEIMIDE-FURANYL COMPOUNDS THAT CAN BE USED IN A GENERAL METHOD FOR PREPARING MALEIMIDE-OLIGONUCLEOTIDE DERIVATIVES | UNIVERSITAT DE BARCELONA (ES) | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | ADM2, VIP, PEPD | CA1 3147/4885CA2 2534/4885CA9 2504/4885 |
| US-10633415-B2 | Processes for preparing pharmaceutically relevant peptides | ADM2, VIP, PEPD | CA1 3147/4885CA2 2534/4885CA9 2504/4885 |
| US-12527854-B2 | Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof | STXBP1, RNGTT, UPF1 | CA1 4068/4885CA2 4557/4885CA9 4739/4885 |
| US-20250002531-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | ADM2, VIP, PEPD | CA1 3147/4885CA2 2534/4885CA9 2504/4885 |
| US-20200308221-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | ADM2, VIP, PEPD | CA1 3147/4885CA2 2534/4885CA9 2504/4885 |
| US-20250152734-A1 | USES AND FORMULATIONS OF CAMPTOTHECIN (CPT)-CONTAINING NANOPARTICLES | MUC1, TOP2A, TOP1 | CA1 748/4885CA2 2192/4885CA9 96/4885 |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | STXBP1, HBB, UPF1 | CA1 3497/4885CA2 4336/4885CA9 4794/4885 |
| US-12037414-B2 | Processes for preparing pharmaceutically relevant peptides | ADM2, VIP, PEPD | CA1 3147/4885CA2 2534/4885CA9 2504/4885 |
| US-20130158248-A1 | MALEIMIDE-FURANYL COMPOUNDS THAT CAN BE USED IN A GENERAL METHOD FOR PREPARING MALEIMIDE-OLIGONUCLEOTIDE DERIVATIVES | NSUN2, POLL, NT5C3B | CA1 1993/4885CA2 1246/4885CA9 1134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.